236 articles 4 sections last published 2026-08-31 independent · no sponsored placements

Fund index

LRGF

3 articles on this site analyse LRGF — 1 of them head-on.

Measured concentration

as of 2026-04-30
297 Holdings (nominal)
54.2 Effective holdings
5.5× Overstatement
33.96% Top 10 weight

LRGF reports 297 positions, but the weights make it behave like about 54.2 equally weighted ones. Computed by this site from the fund's SEC Form N-PORT filing — see what this measure does not tell you and the full table.

The same filing says what kind of price those positions carry: 100% of LRGF is held at a quoted market price, across 10 issuer countries . Comparisons across every fund are in the valuation table, and what a low share does and does not mean is worth reading before drawing a conclusion from it.

Every filing since 2019

27

Between 2019-10-31 and 2026-04-30, LRGF went from behaving like 89.4 equally weighted positions to 54.2 — 39% fewer, while its top ten went from 22.42% to 33.96% of net assets. Read across the funds on the concentration-over-time table.

PeriodHoldingsEffective Top 10Largest
2026-04-30 297 54.2 33.96% 7.51%
2026-01-31 301 53.9 33.81% 7.5%
2025-10-31 289 48.5 35.44% 7.98%
2025-07-31 288 52.3 34.09% 7.49%
2025-04-30 291 63.7 30.32% 6.31%
2025-01-31 280 60.9 32.25% 6.48%
2024-10-31 280 58.5 31.41% 6.6%
2024-07-31 283 59.5 31.21% 6.54%
2024-04-30 289 68.1 29.43% 6.27%
2024-01-31 293 67.4 28.43% 6.7%
2023-10-31 297 61.5 30.09% 6.7%
2023-07-31 309 69.1 27.2% 7.06%
2023-04-30 314 71.5 26.32% 6.71%
2023-01-31 333 89.5 23.09% 5.75%
2022-10-31 319 83.1 24.08% 6.44%
2022-07-31 310 75.8 25.45% 6.47%
2022-04-30 161 81 25.28% 4.47%
2022-01-31 161 79 26.05% 4.67%
2021-10-31 154 78.2 25.99% 4.12%
2021-07-31 154 80.6 25.63% 4.07%
2021-04-30 166 86.1 24.4% 4.07%
2021-01-31 168 82.9 25.18% 4.52%
2020-10-31 145 75.6 26.58% 4%
2020-07-31 147 76.4 26.23% 3.93%
2020-04-30 161 75.8 26.68% 3.47%
2020-01-31 161 87.3 24.01% 3.2%
2019-10-31 165 89.4 22.42% 3.27%

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

Most often compared against

1

Measures applied to it

4

All articles

3

Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.